Expiration date: 06/2025

Excipients:

sodium chloride - 7.59 mg hydrochloric acid q.s.to pH 4.0-6.0, sodium hydroxide - q.s.to pH 4.0-6.0, water d/and - up to 1 ml.

Clinico-pharmacological group:

Local anesthetic

Testimony

At a concentration of 7.5 mg/1 ml and 10 mg/1 ml Ropivacaine Kabi is used v adults and children over 12 years in the following indications:

Anaesthesia with surgical interventions:

• epidural blockade during surgery, including caesarean sections;
  
• the blockade of the major nerves and nerve plexus;
  
• blockade of individual nerves and infiltration anesthesia.
  

Intra-articular injection in knee arthroscopy.

At a concentration of 2 mg/1 ml Ropivacaine Kabi is used in the following indications:

Relief of acute pain in adults and children over 12 years.

• continuous epidural infusion or periodic bolus, for example, to eliminate postoperative pain or analgesia delivery;
  
• blockade of individual nerves and infiltration anesthesia;
  
• extended peripheral nerve blockade by infusion or bolus injection (postoperative pain).
  

Relief of acute pain in children from 1 year to 12 years (inclusive):

• single and continuous peripheral nerve block.
  

Neonates and children up to 12 years of age (inclusive);

• caudal epidural blockade;
  
• continuous epidural infusion.